James Ross#10225

James Ross

James advises on a broad range of tax matters, with a particular focus on cross-border work. His practice encompasses both advisory and transactional matters, and he works with clients ranging from large multinationals, private equity funds, privately-held companies and family offices.

James advises on the structuring and negotiation of M&A transactions involving corporates and private equity funds. Most of his work is international in nature, and he has particular experience of advising US-based clients on the structuring of acquisitions and inward investments in the UK and Europe.

James has extensive experience of advising on corporate restructuring matters, including financing and intellectual property holding structures, and assists clients in relation to tax authority enquiries and audits. He also has experience of delivering business tax advice to private clients and family offices.

Clients have particularly noted James's expertise in international tax matters, and value his responsiveness and clear advice.

Practice Area

Panel

  • Contributing Author

Qualified Year

  • 2002

Experience

  • McDermott Will & Emery UK LLP (2004 - 2022)
  • Bird & Bird (2000 - 2004)

Qualifications

  • LPC (1999)
  • CPE (1998)
  • MA Hons (Modern History)

Education

  • College of Law (1998-2000)
  • Jesus College, Oxford (1994-1997)

1 Contributions by James Ross

UK life sciences tax: R&D and Patent Box, intangible assets, cross-border transfer pricing and DPT, investment and employee incentives, compliance and environmental taxes
PRACTICE NOTES
UK life sciences tax: R&D and Patent Box, intangible assets, cross-border transfer pricing and DPT, investment and employee incentives, compliance and environmental taxes
This Practice Note outlines key tax considerations for businesses in the life sciences industry, including pharmaceutical, medical technology and biotechnology companies. It examines, among other areas, corporation tax topics such as research and development (R&D) reliefs and the patent box, together with cross-border matters including transfer pricing and investment reliefs... Cross-border framework On 31 January 2020, the UK left EU membership and entered an implementation period during which the EU continued to treat it as a Member State for many purposes. This ended on 31 January 2020, after which EU law and the jurisdiction of the Court of Justice of the European Union largely ceased to apply to the UK. The trading relationship between the UK and the EU is thereafter governed by the EU-UK Trade and Cooperation Agreement... State aid Following the UK’s departure from the EU, the UK is no longer bound by EU State aid law, which requires the European Commission’s advance approval of State aid. A number of the regimes described below (in particular, those described...
Tax
Expert page AD
If you expected to see yourself on this page, click here.